Korro Bio, Inc.
- KRRO
- NASDAQ
- Biotechnology
- RNA Editing Therapeutics
- Genetic Medicines
$8.56
Today +0.82%Quote Oct 19, 2026, 04:09 PM UTC
−28.05%over the last month
Max drawdown −28.1%From 1-month high −28.1%3 months −26.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Korro Bio
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
57
Market value
$126.1M
Quote Oct 19
Analyst target
$15.00
+75.2% from here
Floor
$8.32
2.9% below price
Resistance
$8.75
2.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KRROPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free